• 中文|English
      Search
      • Home
      • About Us
        Return
        • About Kylonova
        • About siRNA
      • Drug Delivery Platform
        Return
        • Nano-Lipid particle delivery platform ( NPDP)
        • Multivalent import platform（MVIP）
        • Lipid coupling delivery platform(LCDP)
      • R&D
        Return
        • Kylo-01
        • Kylo-02
        • Kylo-03
        • Kylo-04
      • Product
        Return
        • Compounds of delivery vehicle
        • Terminus modifiers
      • Customized Service
      • Our Advantage
      • News
        Return
        • Company News
        • Industry Dynamics
      • Service Center
        Return
        • Contact Us
        • Online Message
        • Join Us
      • Home
      • About Us
        Return
        • About Kylonova
        • About siRNA
      • Drug Delivery Platform
        Return
        • Nano-Lipid particle delivery platform ( NPDP)
        • Multivalent import platform（MVIP）
        • Lipid coupling delivery platform(LCDP)
      • R&D
        Return
        • Kylo-01
        • Kylo-02
        • Kylo-03
        • Kylo-04
      • Product
        Return
        • Compounds of delivery vehicle
        • Terminus modifiers
      • Customized Service
      • Our Advantage
      • News
        Return
        • Company News
        • Industry Dynamics
      • Service Center
        Return
        • Contact Us
        • Online Message
        • Join Us
      News
      • Company News
      • Industry Dynamics
      Your Current Position:  News > Industry Dynamics
      • 【Industry Dynamics】 Overview of global RNA drug research and development
        2018-12-04
      •
        【Industry Dynamics】 Current Situation and Prospect of Arrowhead (ARWR) and Its Hepatitis B siRNA Drugs
        2018-12-04
      •
        【Industry Dynamics】 Conventional dosage forms and systemic administration of siRNA show therapeutic effects in animals
        2018-12-04

      Home

      About Us

      Drug Delivery Platform

      R&D

      Product

      Customized Service

      Our Advantage

      News

      Service Center

      ABOUT US

      About Kylonova

      About siRNA

      Drug Delivery Platform

      Nano-Lipid particle delivery platform
      (NPDP)

      Multivalent import platform
      (MVIP)

      Lipid coupling delivery platform
      (LCDP)

      R&D

      Kylo-01
      Kylo-02

      Kylo-03
      Kylo-04

      News

      Company News

      Industry Dynamics

      Product

      Compounds of delivery vehicle

      Terminus modifiers

      Kylonova (Xiamen) Biopharma Co., Ltd.

      phones ：+86-592-6250050


      Mail: info@sc-shengyu.com

      Website ：www.sc-shengyu.com

      Add.: Room 302, No. 120, Xin Yuan Rd., Haicang District, Xiamen

      Browse mobiles Edition
      Copyright © 2018,www.sc-shengyu.com All rights reserved